Welcome to our site

Quark Pharmaceuticals , Inc. is a clinical-stage pharmaceutical company that is a leader in the discovery and development of novel RNAi-based therapeutics. Quark has a fully integrated drug development platform. Website Disclaimer...

QUARK is conducting clinical studies in the areas of acute kidney injury associated with major cardiovascular surgery, dela...

Our Products

PF-655 (formerly REDD14NP and RTP801i) is a synthetic siRNA designed to inhibit the expression of Quark’s proprietary target, RTP801...

QPI-1002 (I5NP) is a synthetic siRNA designed to temporarily inhibit expression of the pro-apoptotic protein, p53. Its development is...

Development Pipeline...